Schlusskurse vom 18. September 2026
Die Reihe ist auf die aktuelle Aktienzahl nach Splits umgerechnet; Dividenden sind nicht im Kurs enthalten
| Datum | Eröffnung | Hoch | Tief | Schluss | Volumen, Stück |
|---|---|---|---|---|---|
| 18. September 2026 | 116,80 | 117,82 | 108,41 | 110,29 | 17 Mio. |
| 17. September 2026 | 113,18 | 115,09 | 111,07 | 114,86 | 883.600 |
| 16. September 2026 | 110,82 | 113,60 | 110,49 | 111,81 | 668.600 |
| 15. September 2026 | 111,97 | 112,80 |
Auf Basis der Berichte bis 31. Dezember 2025
Corcept treats a rare hormonal disorder and is trying to apply the same mechanism in oncology.
The lead drug blocks the action of cortisol in a syndrome where the body produces it in excess. The condition is rare, diagnosed late, and treatments were few — the company took that niche and remains profitable, which is unusual for a small pharmaceutical company.
What follows depends on two things: a next-generation drug without the first one's side effects, and applying the same mechanism in ovarian cancer, where early data are encouraging. A constant background is litigation with generic manufacturers, since the active substance has long been known. Risks: patent protection, trial outcomes and the narrowness of the current market. The company pays no dividend.
Adresse:101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065, US
| 1,1 Mrd. |
| PFEPfizer, Inc. | 27,60 | −0,16 % | 949 Mio. |
| ABTAbbott Laboratories | 102,50 | +26,40 % | 833 Mio. |
| VRTXVertex Pharmaceuticals Incorporated | 510,32 | −1,17 % | 554 Mio. |
| BMYBristol-Myers Squibb Company | 62,69 | −0,24 % | 539 Mio. |
| 109,40 |
| 110,82 |
| 1 Mio. |
| 14. September 2026 | 113,38 | 114,52 | 111,10 | 111,80 | 1 Mio. |
| 11. September 2026 | 115,22 | 117,84 | 109,30 | 112,79 | 1 Mio. |
| 10. September 2026 | 114,42 | 116,99 | 113,20 | 114,92 | 683.000 |
| 09. September 2026 | 114,20 | 117,50 | 113,77 | 115,70 | 572.000 |
| 08. September 2026 | 108,87 | 115,28 | 108,25 | 113,98 | 1 Mio. |
| 04. September 2026 | 110,59 | 112,13 | 109,26 | 111,62 | 604.500 |
| 03. September 2026 | 110,38 | 114,61 | 109,43 | 112,80 | 611.100 |
| 02. September 2026 | 113,38 | 115,78 | 108,73 | 110,43 | 960.800 |
| 01. September 2026 | 113,92 | 115,85 | 111,13 | 113,38 | 1 Mio. |
| 31. August 2026 | 113,64 | 114,53 | 111,23 | 113,35 | 636.500 |
| 28. August 2026 | 117,14 | 118,67 | 112,97 | 113,88 | 917.900 |
| 27. August 2026 | 119,25 | 121,30 | 116,70 | 116,93 | 640.500 |
| 26. August 2026 | 122,57 | 123,64 | 119,74 | 119,80 | 980.800 |
| 25. August 2026 | 124,89 | 126,38 | 122,00 | 123,57 | 981.700 |
| 24. August 2026 | 120,56 | 124,14 | 119,17 | 123,24 | 1 Mio. |
| 21. August 2026 | 121,48 | 123,44 | 120,56 | 122,25 | 656.400 |